| Childhood Lymphoma studied in …STUDIED_INderived10 of 98show all (up to 200) |
|---|
| → studied in | NCT03210714Phase 2 · active not recruiting Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial) · condition mapped CURATED_BROADER · 98 trials mapped (15 active) | — | — | Childhood Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05857969Phase 1 · recruiting Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling · condition mapped CURATED_BROADER · 98 trials mapped (15 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03136146Phase 2 · recruiting Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Burkitt Lymphoma/Leukemia, or Double-Hit Lymphoma/Leukemia · condition mapped CURATED_BROADER · 98 trials mapped (15 active) | — | — | Childhood Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02166463Phase 3 · active not recruiting Brentuximab Vedotin and Combination Chemotherapy in Treating Children and Young Adults With Stage IIB, Stage IIIB, IVA, or IVB Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 98 trials mapped (15 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00107198Phase 2 · completed Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease · condition mapped ONTOLOGY_EXACT · 98 trials mapped (15 active) | — | — | Childhood Nodular Lymphocyte Predominant B-Cell Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05418088Phase 1 · recruiting Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies · condition mapped CURATED_BROADER · 98 trials mapped (15 active) | — | — | Childhood Non-Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01190930Phase 3 · completed Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 98 trials mapped (15 active) | — | — | Childhood B Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01920932Phase 2 · active not recruiting Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma · condition mapped CURATED_BROADER · 98 trials mapped (15 active) | — | — | Childhood Hodgkin Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04043494Phase 3 · recruiting International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 98 trials mapped (15 active) | — | — | Childhood Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07221656not yet recruiting Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · condition mapped ONTOLOGY_EXACT · 98 trials mapped (15 active) | — | — | Childhood Lymphoblastic Lymphoma | 1 | Observed | clinicaltrials | graph → |